of esophageal squamous cancer, emphasizing the harmful effects of excessive drinking. This risk is people who lack acetaldehyde and dehydrogenase in the body. In April, the study was published in Journal of Theoracic Oncology.
Cell Death Dis:miR-210-3p regulates the glycolysis in triple-negative breast cancer
Time of Update: 2020-09-23
, the study identified miRNAs that regulate aerobic enzymes and revealed that miR-210-3p had an important contribution to TNBC's Warburg effect.
Solvent-based coatings are banned in the construction decoration industry
Time of Update: 2020-09-23
effective days (203). Environmental protection department monitoring data also show that in January-July this year, the average concentration of PM2.5 in our city was 28.9 micrograms per cubic meter, down 2.7 micrograms per cubic meter from the same
Imported food chaos: "Lee ghost" interfere with the big nutrition has other superstitions must
Time of Update: 2020-09-23
imported food? Is it necessarily safer to eat imported food? Channels, there is a gap in market supervision relative to the traditional import of goods trade, cross-border e-commerce, Haitao and purchasing and other non-goods channels
"Beijing oil chicken" "Beijing duck" DNA freeze preservation
Time of Update: 2020-09-23
the tank is minus 196 degrees, the preservation of more than 70 Holstein cows, Simondal cattle and other excellent varieties of semen. In another low greenhouse, there are ultra-low temperature storage tanks showing minus 79 degrees, where the blood
Gilead has committed $800 million to Jounce to create innovative cancer immunotherapy
Time of Update: 2020-09-23
the key projects currently being developed by Jounce include monoclonal antibody JTX-2011, which stimulates induced costulent molecules, and super-T cells that disrupt target interactions on tumor-related macrophages.
NEJM:BIVV001 maintains long-term high levels of VIII factor activity in patients with severe type A haemophilia
Time of Update: 2020-09-23
the geometric average half-life of BIVV001 is 3 to 4 times that of recombined VIII factors (low dose group: 37.6 vs 9.1 hours, high dose group: 42.5 vs 13.2 hours).
CELL: Single-cell sequencing reveals how drug therapy induced the evolution of lung cancer in humans
Time of Update: 2020-09-23
single-cell map of more than 20,000 cancer and tumor micro-environments (TME) exposes a rich and dynamic tumor ecosystem, and scRNA-seq of cancer cells reveals clinically d'ethonically available targeted cancer genes.
AJOG: CD70 Antibody-Drug Coupler is expected to be a target drug for uterine smooth muscoma
Time of Update: 2020-09-23
researchers first screened target membrane proteins by comparing the expression of membrane proteins in three uterine smooth muscular tumor cell lines (SK-UT-1, SK-LMS-1 and SKN) and normal uterine myoblasts.
Cancer Cell: More powerful! Liao Xuebin/Wei Li collaboration reveals that HPK1 can be a target for T-cell immunotherapy
Time of Update: 2020-09-23
further demonstrated that genetic depletion, pharmacological inhibition, or protein hydrolysis of HPK1 mediated by proTAC can improve the effectiveness of CAR-T cell-based immunotherapy in various preclinical mouse models of blood and solid tumors.
Medtron announces the latest global architecture to accelerate its business orientation strategy
Time of Update: 2020-09-23
technical capabilities and support for use by operating units. the mission of these centers is to continuously develop and effectively share advanced technologies and capabilities across operations to promote innovation and complement their product
What do we buy when we buy fresh food online
Time of Update: 2020-09-23
, and many fresh e-commerce companies have been or are about to be eliminated. Earlier, there was a list of the death of fresh e-commerce, said that since last year, there have been young vegetable king, fresh food club, delicious 77 and other 14 fresh e
NEJM:Tabrecta treats METex14-jumping non-small cell lung cancer with positive results from key studies
Time of Update: 2020-09-23
/missing exon 14 jumps. Jeff Legos, head of oncology development at Novart, said: "The data published today not only confirm our previous positive results in the use of Tabrecta in non-small cell lung cancer, but also highlight the value of early
